Clinical Trial Update: CONTinuous Infusion Versus Intermittent Dosing of ceftaZidime/AVIbactam in Critically Ill Patients [Phase 4]

View source ↗

Summary

This document describes a Phase 4 clinical trial comparing continuous infusion versus intermittent dosing of ceftazidime/avibactam in critically ill patients wi…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infection

Drugs mentioned

• ceftazidime/avibactam (ceftazidime/avibactam)

Snippet

Sponsor: Ivan Šitum, MD | Conditions: Severe Infection | Phase 4 | Status: NOT_YET_RECRUITING